What is DocPlanner?
Established in 2010 and headquartered in Warsaw, Poland, DocPlanner.com is a leading developer of appointment booking and management software tailored for healthcare providers. The platform serves a broad network of medical professionals across Europe and Latin America, streamlining administrative processes and enhancing patient access to care. DocPlanner's comprehensive solution facilitates efficient scheduling, patient communication, and practice management, positioning it as a critical technology partner for the healthcare industry.
How much funding has DocPlanner raised?
DocPlanner has raised a total of $140.4M across 6 funding rounds:
Other Financing Round
$1M
Series A
$3M
Series B
$10M
Series C
$20M
Series D
$16.8M
Other Financing Round
$89.6M
Other Financing Round (2012): $1M with participation from Piton Capital and RTAventures VC
Series A (2013): $3M led by RTAventures VC and Piton Capital
Series B (2015): $10M supported by Piton Capital, Point Nine, and RTAventures
Series C (2016): $20M featuring EBRD and Target Global
Series D (2017): $16.8M backed by Target Global, Enern Investments, and One Peak Partners
Other Financing Round (2019): $89.6M with participation from ENERN Investments, One Peak Partners, Goldman Sachs Private Capital Investing, and Piton Capital
Key Investors in DocPlanner
Goldman Sachs Private Capital Investing
Goldman Sachs is a leading global investment banking firm providing a wide range of financial services. Their Private Capital Investing arm focuses on providing capital to growing companies.
Target Global
Target Global is a pan-European technology investment firm that invests in companies across all stages of their lifecycle, from pre-seed to pre-IPO, with a portfolio exceeding 140 investments.
Piton Capital
Piton Capital specializes in investing in online businesses that exhibit network effects, operating in major cities like London and Amsterdam, and focusing on ventures that leverage interconnectedness for growth.
What's next for DocPlanner?
With its history of significant enterprise-level funding, DocPlanner is well-positioned for continued expansion and innovation. The company's strategic investments suggest a focus on scaling its operations, enhancing its technological infrastructure, and potentially exploring new market opportunities. Future developments are likely to center on further integrating advanced features into its platform, such as AI-driven patient engagement tools or expanded telemedicine capabilities, to maintain its competitive edge and drive further growth in the global digital health landscape.
See full DocPlanner company page
